help button home button Am J Pathol PCR Enhanced. PCRboost from Biomatrica
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Premkumar, D. R.
Right arrow Articles by Kalaria, R. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Premkumar, D. R.
Right arrow Articles by Kalaria, R. N.

American Journal of Pathology, Vol 148, 2083-2095, Copyright © 1996 by American Society for Investigative Pathology

REGULAR ARTICLES

Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease

DR Premkumar, DL Cohen, P Hedera, RP Friedland and RN Kalaria
Department of Neurology, Case Western Reserve University, Cleveland, Ohio 44106-4938, USA.

The presence of apolipoprotein E-epsilon4 (APOE-epsilon4) allele has been implicated as a risk factor for Alzheimer's disease (AD). We examined the frequencies of APOE-epsilon4 alleles in age-matched controls and subgroups of 190 AD subjects exhibited cerebral amyloid angiopathy (CAA) and other frequently associated lesions. CAA was evident in 96% of the AD subjects, which were divided into two groups, one bearing mild or no apparent CAA and the other with moderate to severe CAA. APOE-epsilon4 allele frequency (48%) in the latter advanced CAA group was six times higher than in those who exhibited mild CAA. In the advanced CAA subjects, the occurrence of an epsilon4 allele was increased by a factor of 17 (95% confidence interval, 7.56 to 38.9). This was despite the fact that neocortical amyloid-beta plaque densities in the two groups were similar and that all of the AD subjects had met the accepted neuropathological criteria. We also observed that the degree of CAA severity was greatest in the group of subjects with the epsilon4/epsilon4 genotype. The association between CAA and APOE-epsilon4 was further implicated in two non-AD subjects among neurological controls with severe CAA. These two subjects, both homozygous for the APOE-epsilon4 allele, were primarily diagnosed as having Creutzfeldt-Jakob disease and Pick's disease in the absence of significant neocortical amyloid deposition. Allele frequency comparisons between neurological control subjects with CAA and those without likewise accorded a strong relationship between the APOE- epsilon4 allele and the presence of CAA. More remarkably, the epsilon4 allele frequency was highly associated with AD subjects exhibiting lobar or intracerebral hemorrhage, all of whom had advanced CAA. We observed that 36% of the AD subjects had concomitant cerebrovascular pathology resulting from single infarcts, multiple microinfarcts, ischemic white matter lesions, or petechial hemorrhages. Although the difference in APOE genotype distribution between subjects with and without cerebrovascular lesions did not reach statistical significance, we did note that the frequency of the epsilon4 allele was significantly higher in subjects with such pathology as compared with those without. However, we found no evidence to suggest that the acquisition of an APOE-epsilon4 allele or one of the alleles, epsilon2 or epsilon3, was a factor in the occurrence of atherosclerosis localized in the basal surface arteries. Analyses of our sample also confirm that there was a lower frequency of the APOE-epsilon2 allele in AD subjects and that the frequency of the epsilon4 allele in AD subjects with concomitant diffuse Lewy body disease was intermediate between controls and AD subjects. Our results suggest that the APOE-epsilon4 allele is a significant factor in the development of CAA in AD and reveal the possibility that APOE is an independent factor in CAA and other vascular abnormalities associated with AD.


This article has been cited by other articles:


Home page
 NeurologyHome page
M. W. Vernooij, A. van der Lugt, M. A. Ikram, P. A. Wielopolski, W. J. Niessen, A. Hofman, G. P. Krestin, and M.M.B. Breteler
Prevalence and risk factors of cerebral microbleeds: The Rotterdam Scan Study
Neurology, April 1, 2008; 70(14): 1208 - 1214.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
C. Kinnecom, M. H. Lev, L. Wendell, E. E. Smith, J. Rosand, M. P. Frosch, and S. M. Greenberg
Course of cerebral amyloid angiopathy-related inflammation
Neurology, April 24, 2007; 68(17): 1411 - 1416.
[Abstract] [Full Text] [PDF]

Home page
 AJGPHome page
E. J. Burton, I. G. McKeith, D. J. Burn, M. J. Firbank, and J. T. O'Brien
Progression of White Matter Hyperintensities in Alzheimer Disease, Dementia With Lewy Bodies, and Parkinson Disease Dementia: A Comparison With Normal Aging
Am J Geriatr Psychiatry, October 1, 2006; 14(10): 842 - 849.
[Abstract] [Full Text] [PDF]

Home page
 J. Gerontol. A Biol. Sci. Med. Sci.Home page
J. A. H. R. Claassen and R. W. M. M. Jansen
Cholinergically mediated augmentation of cerebral perfusion in Alzheimer's disease and related cognitive disorders: the cholinergic-vascular hypothesis.
J. Gerontol. A Biol. Sci. Med. Sci., March 1, 2006; 61(3): 267 - 271.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Neuroradiol.Home page
R. van den Boom, S.A.J. Lesnick Oberstein, A.A. van den Berg-Huysmans, M.D. Ferrari, M.A. van Buchem, and J. Haan
Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy: Structural MR Imaging Changes and Apolipoprotein E Genotype.
AJNR Am. J. Neuroradiol., February 1, 2006; 27(2): 359 - 362.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
A. G. Yip, A. C. McKee, R. C. Green, J. Wells, H. Young, L. A. Cupples, and L. A. Farrer
APOE, vascular pathology, and the AD brain
Neurology, July 26, 2005; 65(2): 259 - 265.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurol. Neurosurg. PsychiatryHome page
T Hamaguchi, S Okino, N Sodeyama, Y Itoh, A Takahashi, E Otomo, M Matsushita, H Mizusawa, and M Yamada
Association of a polymorphism of the transforming growth factor-{beta}1 gene with cerebral amyloid angiopathy
J. Neurol. Neurosurg. Psychiatry, May 1, 2005; 76(5): 696 - 699.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
J.A. Schneider, J.L. Bienias, R.S. Wilson, E. Berry-Kravis, D.A. Evans, and D.A. Bennett
The Apolipoprotein E {epsilon}4 Allele Increases the Odds of Chronic Cerebral Infarction Detected at Autopsy in Older Persons
Stroke, May 1, 2005; 36(5): 954 - 959.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
M. M. M. Wilhelmus, I. Otte-Holler, J. Davis, W. E. Van Nostrand, R. M. W. de Waal, and M. M. Verbeek
Apolipoprotein E Genotype Regulates Amyloid-{beta} Cytotoxicity
J. Neurosci., April 6, 2005; 25(14): 3621 - 3627.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
L. S. Honig, W. Kukull, and R. Mayeux
Atherosclerosis and AD: Analysis of data from the US National Alzheimer's Coordinating Center
Neurology, February 8, 2005; 64(3): 494 - 500.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurol. Neurosurg. PsychiatryHome page
P D Leclercq, L S Murray, C Smith, D I Graham, J A R Nicoll, and S M Gentleman
Cerebral amyloid angiopathy in traumatic brain injury: association with apolipoprotein E genotype
J. Neurol. Neurosurg. Psychiatry, February 1, 2005; 76(2): 229 - 233.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
S. M. Greenberg, J. A. Eng, M. Ning, E. E. Smith, and J. Rosand
Hemorrhage Burden Predicts Recurrent Intracerebral Hemorrhage After Lobar Hemorrhage
Stroke, June 1, 2004; 35(6): 1415 - 1420.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
D. Woo, B. M. Kissela, J. C. Khoury, L. R. Sauerbeck, M. A. Haverbusch, J. P. Szaflarski, J. M. Gebel, A. M. Pancioli, E. C. Jauch, A. Schneider, et al.
Hypercholesterolemia, HMG-CoA Reductase Inhibitors, and Risk of Intracerebral Hemorrhage: A Case-Control Study
Stroke, June 1, 2004; 35(6): 1360 - 1364.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurol. Neurosurg. PsychiatryHome page
J Tian, J Shi, K Bailey, C L Lendon, S M Pickering-Brown, and D M A Mann
Association between apolipoprotein E e4 allele and arteriosclerosis, cerebral amyloid angiopathy, and cerebral white matter damage in Alzheimer's disease
J. Neurol. Neurosurg. Psychiatry, May 1, 2004; 75(5): 696 - 699.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
P. Tiraboschi, M. N. Sabbagh, L. A. Hansen, D. P. Salmon, A. Merdes, A. Gamst, E. Masliah, M. Alford, L. J. Thal, and J. Corey-Bloom
Alzheimer disease without neocortical neurofibrillary tangles: "A second look"
Neurology, April 13, 2004; 62(7): 1141 - 1147.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurol. Neurosurg. PsychiatryHome page
S Love
Contribution of cerebral amyloid angiopathy to Alzheimer's disease
J. Neurol. Neurosurg. Psychiatry, January 1, 2004; 75(1): 1 - 4.
[Full Text] [PDF]

Home page
 BrainHome page
J. M. Heckmann, W.-C. Low, C. de Villiers, S. Rutherfoord, A. Vorster, H. Rao, C. M. Morris, R. S. Ramesar, and R. N. Kalaria
Novel presenilin 1 mutation with profound neurofibrillary pathology in an indigenous Southern African family with early-onset Alzheimer's disease
Brain, January 1, 2004; 127(1): 133 - 142.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurol. Neurosurg. PsychiatryHome page
M Yamada, N Sodeyama, Y Itoh, A Takahashi, E Otomo, M Matsushita, and H Mizusawa
Association of neprilysin polymorphism with cerebral amyloid angiopathy
J. Neurol. Neurosurg. Psychiatry, June 1, 2003; 74(6): 749 - 751.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
M. Yamada, N. Sodeyama, Y. Itoh, E. Otomo, M. Matsushita, and H. Mizusawa
No Association of Paraoxonase Genotype or Atherosclerosis With Cerebral Amyloid Angiopathy
Stroke, April 1, 2002; 33(4): 896 - 900.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
J.C. de la Torre
Alzheimer Disease as a Vascular Disorder: Nosological Evidence
Stroke, April 1, 2002; 33(4): 1152 - 1162.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
K. A. Knudsen, J. Rosand, D. Karluk, and S. M. Greenberg
Clinical diagnosis of cerebral amyloid angiopathy: Validation of the Boston Criteria
Neurology, February 27, 2001; 56(4): 537 - 539.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
J. Rosand, E. M. Hylek, H. C. O'Donnell, and S. M. Greenberg
Warfarin-associated hemorrhage and cerebral amyloid angiopathy: A genetic and pathologic study
Neurology, October 10, 2000; 55(7): 947 - 951.
[Abstract] [Full Text] [PDF]

Home page
 Arch NeurolHome page
J.-H. Lee, J. M. Olichney, L. A. Hansen, C. R. Hofstetter, and L. J. Thal
Small Concomitant Vascular Lesions Do Not Influence Rates of Cognitive Decline in Patients With Alzheimer Disease
Arch Neurol, October 1, 2000; 57(10): 1474 - 1479.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
F. C. Crawford, M. J. Freeman, J. A. Schinka, L. I. Abdullah, M. Gold, R. Hartman, K. Krivian, M. D. Morris, D. Richards, R. Duara, et al.
A polymorphism in the cystatin C gene is a novel risk factor for late-onset Alzheimer's disease
Neurology, September 26, 2000; 55(6): 763 - 768.
[Abstract] [Full Text] [PDF]

Home page
 Arch NeurolHome page
J. M. Olichney, L. A. Hansen, C. R. Hofstetter, J.-H. Lee, R. Katzman, and L. J. Thal
Association Between Severe Cerebral Amyloid Angiopathy and Cerebrovascular Lesions in Alzheimer Disease Is Not a Spurious One Attributable to Apolipoprotein E4
Arch Neurol, June 1, 2000; 57(6): 869 - 874.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurol. Neurosurg. PsychiatryHome page
H. Sawada, F. Udaka, Y. Izumi, K. Nishinaka, H. Kawakami, S. Nakamura, and M. Kameyama
Cerebral white matter lesions are not associated with apoE genotype but with age and female sex in Alzheimer's disease
J. Neurol. Neurosurg. Psychiatry, May 1, 2000; 68(5): 653 - 656.
[Abstract] [Full Text]

Home page
 NEJMHome page
H. C. O'Donnell, J. Rosand, K. A. Knudsen, K. L. Furie, A. Z. Segal, R. I. Chiu, D. Ikeda, and S. M. Greenberg
Apolipoprotein E Genotype and the Risk of Recurrent Lobar Intracerebral Hemorrhage
N. Engl. J. Med., January 27, 2000; 342(4): 240 - 245.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
M. Yamada, N. Sodeyama, Y. Itoh, N. Suematsu, E. Otomo, M. Matsushita, and H. Mizusawa
A Deletion Polymorphism of {alpha}2-Macroglobulin Gene and Cerebral Amyloid Angiopathy
Stroke, November 1, 1999; 30 (11): 2277 - 2279.
[Abstract] [Full Text] [PDF]

Home page
 Arch NeurolHome page
R. Barber, A. Gholkar, P. Scheltens, C. Ballard, I. G. McKeith, C. M. Morris, and J. T. O'Brien
Apolipoprotein E {epsilon}4 Allele, Temporal Lobe Atrophy, and White Matter Lesions in Late-Life Dementias
Arch Neurol, August 1, 1999; 56(8): 961 - 965.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
M. Yamada, N. Sodeyama, Y. Itoh, N. Suematsu, E. Otomo, M. Matsushita, and H. Mizusawa
Butyrylcholinesterase K Variant and Cerebral Amyloid Angiopathy
Stroke, December 1, 1998; 29(12): 2488 - 2490.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
M. Yamada, N. Sodeyama, Y. Itoh, N. Suematsu, E. Otomo, M. Matsushita, and H. Mizusawa
Association of Presenilin-1 Polymorphism With Cerebral Amyloid Angiopathy in the Elderly
Stroke, November 1, 1997; 28(11): 2219 - 2221.
[Abstract] [Full Text]

Home page
 StrokeHome page
S. M. Greenberg and J.-P. G. Vonsattel
Diagnosis of Cerebral Amyloid Angiopathy : Sensitivity and Specificity of Cortical Biopsy
Stroke, July 1, 1997; 28(7): 1418 - 1422.
[Abstract] [Full Text]

Home page
 StrokeHome page
S. M. Greenberg, M. E. Briggs, B. T. Hyman, G. J. Kokoris, C. Takis, D. S. Kanter, C. S. Kase, and M. S. Pessin
Apolipoprotein E {epsilon}4 Is Associated With the Presence and Earlier Onset of Hemorrhage in Cerebral Amyloid Angiopathy
Stroke, August 1, 1996; 27(8): 1333 - 1337.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1996 by the American Society for Investigative Pathology.